Sigma Planning Corp’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,781
| Closed | -$420K | – | 1358 |
|
|
2022
Q3 | $420K | Buy |
2,781
+279
| +11% | +$42.1K | 0.02% | 802 |
|
|
2022
Q2 | $365K | Sell |
2,502
-3,984
| -61% | -$581K | 0.01% | 890 |
|
|
2022
Q1 | $769K | Buy |
6,486
+386
| +6% | +$45.8K | 0.02% | 645 |
|
|
2021
Q4 | $841K | Sell |
6,100
-268
| -4% | -$36.9K | 0.02% | 614 |
|
|
2021
Q3 | $885K | Sell |
6,368
-940
| -13% | -$131K | 0.03% | 586 |
|
|
2021
Q2 | $709K | Sell |
7,308
-1,229
| -14% | -$119K | 0.02% | 675 |
|
|
2021
Q1 | $584K | Buy |
8,537
+827
| +11% | +$56.6K | 0.02% | 699 |
|
|
2020
Q4 | $661K | Sell |
7,710
-5,913
| -43% | -$507K | 0.02% | 574 |
|
|
2020
Q3 | $886K | Sell |
13,623
-720
| -5% | -$46.8K | 0.04% | 432 |
|
|
2020
Q2 | $1.05M | Sell |
14,343
-3,513
| -20% | -$257K | 0.05% | 378 |
|
|
2020
Q1 | $608K | Buy |
17,856
+988
| +6% | +$33.6K | 0.04% | 431 |
|
|
2019
Q4 | $918K | Sell |
16,868
-2,100
| -11% | -$114K | 0.04% | 424 |
|
|
2019
Q3 | $791K | Sell |
18,968
-900
| -5% | -$37.5K | 0.04% | 438 |
|
|
2019
Q2 | $870K | Buy |
19,868
+5,152
| +35% | +$226K | 0.04% | 379 |
|
|
2019
Q1 | $757K | Sell |
14,716
-192
| -1% | -$9.88K | 0.04% | 381 |
|
|
2018
Q4 | $551K | Buy |
14,908
+1,807
| +14% | +$66.8K | 0.04% | 406 |
|
|
2018
Q3 | $492K | Sell |
13,101
-360
| -3% | -$13.5K | 0.03% | 488 |
|
|
2018
Q2 | $532K | Sell |
13,461
-3,680
| -21% | -$145K | 0.04% | 437 |
|
|
2018
Q1 | $442K | Buy |
17,141
+1,338
| +8% | +$34.5K | 0.03% | 468 |
|
|
2017
Q4 | $426K | Buy |
15,803
+800
| +5% | +$21.6K | 0.03% | 483 |
|
|
2017
Q3 | $561K | Buy |
+15,003
| New | +$561K | 0.05% | 389 |
|